Aytu Biopharma Inc (AYTU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2020 | 06-2019 | 06-2018 | 06-2017 | 06-2016 | |
| Sales | 27,632 | 7,320 | 3,660 | 3,222 | 2,562 |
| Cost of Goods | 8,281 | 2,202 | 2,051 | 1,417 | 957 |
| Gross Profit | 19,351 | 5,118 | 1,610 | 1,804 | 1,605 |
| Operating Expenses | 40,763 | 22,167 | 21,360 | 22,347 | 24,267 |
| Operating Income | -21,131 | -16,847 | -19,700 | -20,125 | -21,704 |
| Interest Expense | 0 | 536 | 749 | 2,534 | 5,492 |
| Other Income | 7,510 | -9,750 | 10,262 | 151 | -984 |
| Pre-tax Income | -13,621 | -27,132 | -10,188 | -22,508 | -28,180 |
| Net Income Continuous | -13,621 | -27,132 | -10,188 | -22,508 | -28,180 |
| Net Income | $-13,621 | $-27,132 | $-10,188 | $-22,508 | $-28,180 |
| EPS Basic Total Ops | -60.20 | -696.00 | -3,062.00 | -9,660.00 | -1,294,800.00 |
| EPS Basic Continuous Ops | -60.28 | -696.23 | -3,061.23 | -9,659.72 | -1,294,788.00 |
| EPS Diluted Total Ops | -60.20 | -696.00 | -3,062.00 | -9,660.00 | -1,294,800.00 |
| EPS Diluted Continuous Ops | -60.28 | -696.23 | -3,061.23 | -9,659.72 | -1,294,788.00 |
| EBITDA(a) | $-14,885 | $-14,120 | $-17,109 | $-15,425 | $-15,582 |